AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Clinical trial NCT02780830 · WITHDRAWN

Trial details

NCT number: NCT02780830
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma Module 1: Non-GCB Diffuse Large B-Cell Lymphoma

Start date: 2016-06-01
Primary completion: 2019-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.